Patent Assignment
Reel/Frame 046599/0987
Nunc Pro Tunc Assignment
Recorded: 2018-08-09
Pages: 6
Assignor
TRIUS THERAPEUTICS LLC
Executed: 2015-07-22
Assignee
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NEW JERSEY, 07065
Covered Properties
(3)
Forms of R)-3-(4-(2-(2-Methyltetrazol-5-Yl)Pyridin-5-Yl)-3-Fluorophenyl)-5-Hydroxymethyl Oxazolidin-2-One Dihydrogen Phosphate
Forms of R)-3-(4-(2-(2-Methyltetrazol-5-Yl)Pyridin-5-Yl)-3-Fluorophenyl)-5-Hydroxymethyl Oxazolidin-2-One Dihydrogen Phosphate
Forms of R)-3-(4-(2-(2-Methyltetrazol-5-Yl)Pyridin-5-Yl)-3-Fluorophenyl)-5-Hydroxymethyl Oxazolidin-2-One Dihydrogen Phosphate
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Certificate of Conversion
Aug 9, 2018
From: TRIUS THERAPEUTICS, INC.
To: TRIUS THERAPEUTICS LLC
Reel/Frame 047450/0652 →
Assignment of Assignor's Interest
Aug 9, 2018
From: REICHENBACHER, KATHARINA; DUGUID, ROBERT J.; PHILLIPSON, DOUGLAS; SIMSON, JACQUELINE A.
To: TRIUS THERAPEUTICS
Reel/Frame 046599/0838 →
Merger
Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →